These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6167819)

  • 41. Arrhythmogenic assessment of prenalterol in conscious dogs.
    Aberg G; Jannou G; Meeker J; Olson R; Persson BA; Povalski H
    Acta Pharmacol Toxicol (Copenh); 1983 Aug; 53(2):141-5. PubMed ID: 6624482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
    Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
    Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
    [No Abstract]   [Full Text] [Related]  

  • 43. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine.
    Fowler MB; Alderman EL; Oesterle SN; Derby G; Daughters GT; Stinson EB; Ingels NB; Mitchell RS; Miller DC
    Circulation; 1984 Sep; 70(3 Pt 2):I103-11. PubMed ID: 6744557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure.
    Fitzpatrick D; Ikram H; Nicholls MG; Espiner EA
    Circulation; 1983 Mar; 67(3):613-9. PubMed ID: 6821903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prenalterol in cardiogenic shock following acute myocardial infarction.
    Coma-Canella I; Lopez-Sendon J; Jadraque LM
    Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in man.
    Steen PA; Tinker JH; Pluth JR; Barnh;rst DA; Tarhan S
    Circulation; 1978 Feb; 57(2):378-84. PubMed ID: 618630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine.
    Boncyk J; Redon D; Rusy B
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):347-54. PubMed ID: 6463363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.
    Meyer SL; Curry GC; Donsky MS; Twieg DB; Parkey RW; Willerson JT
    Am J Cardiol; 1976 Jul; 38(1):103-8. PubMed ID: 937182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
    Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
    Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consequences of regional inotropic stimulation of ischemic myocardium on regional myocardial blood flow and function in anesthetized swine.
    Schulz R; Miyazaki S; Miller M; Thaulow E; Heusch G; Ross J; Guth BD
    Circ Res; 1989 Jun; 64(6):1116-26. PubMed ID: 2720914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
    Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
    Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute haemodynamic effects of oral prenalterol in severe heart failure.
    Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
    Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Positive inotropic agents. Generalities and classification].
    Vahanian A; Le Potier J; Sergent J; Michel PL; Acar J
    Ann Med Interne (Paris); 1985; 136(3):242-6. PubMed ID: 2862822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1087-95. PubMed ID: 1602375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of dobutamine and dopamine in treatment of severe heart failure.
    Stoner JD; Bolen JL; Harrison DC
    Br Heart J; 1977 May; 39(5):536-9. PubMed ID: 324501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardioselectivity of dobutamine and prenalterol in the pentobarbital anesthetized dog.
    Strosberg AM; Montgomery W
    Proc West Pharmacol Soc; 1981; 24():83-7. PubMed ID: 7255492
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of dopamine and dobutamine therapy during intraaortic balloon pumping for the treatment of postcardiotomy low-output syndrome.
    Sterling RP; Taegtmeyer H; Turner SA; Walker WE; Cooley DA
    Ann Thorac Surg; 1984 Jul; 38(1):37-41. PubMed ID: 6610395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
    Tydén H; Johansson L; Nyström SO
    Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.